Athersys (NASDAQ: ATHX)
Some price data may be temporarily unavailable.
Athersys Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Athersys Company Info
Athersys, Inc. is a biotechnology company, which focuses on the field of regenerative medicine. It engages in the discovery and development of therapies designed to extend and enhance the quality of human life. The firm offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH.
News & Analysis
Why Athersys Stock Jumped Today
The biotech's partner completed enrollment in a key clinical study.
Why Athersys Stock Jumped Today
The biotech announced the enrollment of the first patient in a key clinical study.
Here's Why Athersys Stock Is Soaring Today
The stem cell stock jumped after a major Wall Street firm initiated coverage, but there's a catch.
Here's Why Athersys Rose 26.5% in May
The stem cell stock recovered from a lousy April as the company fed investors updates for its COVID-19 programs.
Here's Why Athersys Tumbled 23.3% in April
The stem cell stock has delivered a 100% gain since the beginning of the year. Can it hold?
Are Stem Cells the COVID-19 Treatment We've All Been Waiting For?
Promising results from a very small study caused shares of stem cell stocks to soar, but investors shouldn't get too carried away just yet.
Athersys Stock Tumbles as Much as 27.7% on a Public Offering
The stem cell developer decided to wisely take advantage of a soaring share price to raise funds.
Here's Why Athersys Rose as Much as 15.2% Today
The FDA has given the company's lead drug platform a potential leg up in development.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.